Ocean Biomedical enters first in-human clinical trial

Updated at 3:45 p.m.

PROVIDENCE – Ocean Biomedical, a biopharmaceutical company launched out of Brown University, is entering its first in-human clinical trial with Virion Therapeutics LLC, a Delaware-based company that is moving to Philadelphia.  Ocean Biomedical announced Thursday it is helping expand Virion’s clinical-stage program and pipeline of VRON-0200, a treatment for patients with chronic hepatitis B, a…

Thanks for reading Providence Business News. Create your free account or log in to continue reading.

Register Now Already a Subscriber? Login now


If you have already logged in and are still seeing this message, please refresh the page as your browser is caching the old content.

- Advertisement -

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.